Using a severity questionnaire for allergic rhinitis during ENT visits
Official title: Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations
Run by University Hospital, Strasbourg, France · NCT07315945 · Data updated 2026-11-12
This project will try a short severity questionnaire during ENT follow-ups for adults with allergic rhinitis to see if patients find it acceptable and if the scores reliably reflect symptom severity.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | June 10, 2025 |
| Main results expected | February 2026 |
| Study ends | February 2026 |
| Registry record updated | January 5, 2026 |
| Trial ID | NCT07315945 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18 years and older) who are followed at the ENT department of Hautepierre University Hospital for allergic rhinitis are ideal candidates.
✕Probably not a fit
Asymptomatic individuals or people not needing ENT follow-up are unlikely to receive benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project introduces the SCST (French CSMS) and SNOT-22 questionnaires into routine ENT follow-up visits for adults with allergic rhinitis at Hautepierre University Hospital. Patients complete the questionnaires during consultations while clinicians record clinical findings and management decisions. Investigators will analyze acceptability, internal consistency, reliability, and responsiveness of the scores and examine how questionnaire results correlate with clinical status over time. The aim is to determine whether routine use yields consistent, usable data for patient care and for pooling in future research.
Why it matters
Potential benefit: If successful, routine use of a validated severity questionnaire could make follow-up visits more consistent and help clinicians tailor treatments while generating comparable data for better long-term care.
How similar studies have gone: Similar patient-reported severity scores (such as CSMS/SCST and SNOT-22) have been used and partially validated in prior work, but local acceptability and detailed statistical properties still need confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (≥18 years) * Follow-up at the ENT department of Hautepierre University Hospital for allergic rhinitis Exclusion Criteria: * Asymptomatic individuals not requiring follow-up consultations.
Where it's running
-
Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Léa FATH, MD
- Email: lea.fath@chru-strasbourg.fr
- Phone: 33 3 88 12 76 52
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mannan-Conjugated Allergoids for House Dust M mite Allergy
A new treatment named EP-088_MM09 is being tested to see if it can reduce nasal and eye allergy symptoms (and possibly asthma) in people aged 12 to 65 who are allergic to house dust mites, compared with a placebo.
-
Mannan-conjugated Allergoids for House Dust Mite Allergy
A new treatment called EP-088_MM09 is being tested to see if it can reduce allergy symptoms in people with house dust mite–related nasal allergy, with or without mild asthma.
-
Dog-allergy immunotherapy with Alutard SQ Dog in Swedish practice
This study tests whether Alutard SQ Dog immunotherapy helps adults with moderate-to-severe dog allergy when used in real-world Swedish care.
-
PL-14 Allergy Blocker vs saline spray for seasonal nasal allergies
This study tests whether PL-14 Allergy Blocker, a drug-free nasal gel, reduces nasal allergy symptoms in adults with seasonal allergic rhinitis compared with saline spray.
-
Helping decide between nasal surgery options for chronic hypertrophic rhinitis
A randomized trial will see if a printed patient decision aid helps adults with chronic hypertrophic rhinitis choose between surgical options more confidently and with less regret.
-
Digital app to improve adherence to aeroallergen immunotherapy
This project will test whether a smartphone app can help people with allergic rhinitis keep taking their prescribed aeroallergen immunotherapy for the full treatment course.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.